DCF — WILLAMETTE VALLEY MEDICAL CENTER
Enterprise Value: $-114.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-114.8M
Enterprise Value
$-37.7M
PV of Cash Flows
$-77.1M
PV of Terminal Value
$-124.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $113.7M | $-6.4M | -6.0% | $-11.2M | $-10.2M |
| Year 2 | $117.2M | $-5.4M | -5.0% | $-10.4M | $-8.6M |
| Year 3 | $120.7M | $-4.4M | -4.0% | $-9.5M | $-7.1M |
| Year 4 | $124.3M | $-3.9M | -3.0% | $-9.1M | $-6.2M |
| Year 5 | $128.0M | $-3.7M | -3.0% | $-9.1M | $-5.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-114.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$110.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06113090998153557
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5